TJ-L1T6

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTJ-L1T6

Drug Alias NameTJ-L1T6

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionT cell immunoglobulin and ITIM domains inhibitorsProgrammed death-ligand 1 blockers

TargetsT cell immunoglobulin and ITIM domainsProgrammed death-ligand 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesI-Mab Biopharma Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesI-Mab Biopharma Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A